1-4 of 4
David Scadden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transcriptional Co-Activator P300 Promotes Extra-Medullary Disease Formation and Myeloma Disease Progression

Rajib Shome, Srikanth Talluri, Tsuyoshi Fukushima, Mehmet K. Samur, Rie Nakamoto-Matsubara, Cristina Panaroni, Keertik Fulzele, Kiyosumi Ochi, Ryan Seongmin Han, Farah Rexha, David Scadden, Nikhil C Munshi, Noopur S. Raje
Journal: Blood
Blood (2023) 142 (Supplement 1): 1939.
https://doi.org/10.1182/blood-2023-189362
Published: 2023
Journal Articles

VEGF-C protects the integrity of the bone marrow perivascular niche in mice

Shentong Fang, Shuo Chen, Harri Nurmi, Veli-Matti Leppänen, Michael Jeltsch, David Scadden, Lev Silberstein, Hanna Mikkola, Kari Alitalo
Journal: Blood
Blood (2020) 136 (16): 1871–1883.
https://doi.org/10.1182/blood.2020005699
Published: 2020
Includes: Supplemental data
Journal Articles

Promoting Osteoblastogenesis Using a Novel Dkk-1 Neutralizing Antibody in the Treatment of Multiple Myeloma Related Bone Disease

Samantha Pozzi, MD, Hua Yan, MD, Sonia Vallet, M.D., Nileshwari Vaghela, MS, Mariateresa Fulciniti, PhD, Diana Cirstea, MD, Loredana Santo, M.D., Siddhartha Mukherjee, MD, Teru Hideshima, M.D., Ph.D., Linda Schirtzinger, M.S., Stuart Kuhstoss, Nikhil C. Munshi, MD, Kenneth C Anderson, MD, David Scadden, MD, Noopur Raje, MD
Journal: Blood
Blood (2008) 112 (11): 2739.
https://doi.org/10.1182/blood.V112.11.2739.2739
Published: 2008
Journal Articles

Dose Adjusted IV Busulfan/Cyclophosphamide (BU/CY) and Autologous (AU) Stem Cell Transplantation (SCT) for Recurrent Lymphoma.

Thomas R. Spitzer, MD, Benjamin Cox, Paul Sepe, Steven L. McAfee, MD, Bimalangshu R. Dey, MD, Karen Ballan, MD, David Scadden, MD
Journal: Blood
Blood (2004) 104 (11): 1884.
https://doi.org/10.1182/blood.V104.11.1884.1884
Published: 2004